The PharmTrain clinical fellowship involves fellows from the national medicines regulatory authorities (NMRAs) in Ghana, Zimbabwe, Tanzania and South Africa, i.e. from three different economic regions, thus covering large parts of Sub-Sahara Africa. This group committed to an intensive, multi-year journey to acquire both technical expertise and didactic skills within…
Context Low-quality drugs pose a substantial threat to individual and public health. Issues include incorrect labelling, potentially toxic or wrong active ingredients and unacceptably high levels of impurities. Low-quality anti-infective medicines, in particular, pose a potentially global concern as they can lead to the development of antimicrobial resistance, making the…
Biosimilars and their importance for the African Continent Biotechnologically manufactured medicines are becoming more and more important, especially for the treatment of cancer, diabetes, and viral diseases. These products are often very expensive due to their complex development and manufacturing processes. However, after a certain period, these products may be…
The AMRH Week: A landmark in the operationalization of the African Medicines Agency PharmTrain, a technical partner of the African Medicines Regulatory Harmonization (AMRH) initiative, and member of the Coalition of Interested Parties (CIP), participated in the “3rd AMRH Week” in Accra, Ghana in December 2022. This biennial conference is…
Context Global health crises are on the rise, especially those caused by infectious disease outbreaks, and pose a serious threat to health and well-being. WHO estimates that up to 10 million lives could be saved every year if access to safe and effective medicines and vaccines were improved. As a…
Short description Challenges Addressed by the Project Capacity building is an important component of GHPP projects. It requires training and mentoring, learning and practice, and constant exchange. Due to time, cost or environmental reasons, this cannot always take place face-to-face. Therefore, the use of electronic forms and means of communication…
Short Description The recurrent Ebola epidemics of recent years, as well as other infectious diseases widespread in Africa such as HIV, tuberculosis or malaria, show that effective and safe medicines for the prevention and treatment of these infectious diseases are not, or not sufficiently, available. Under the umbrella name “RegTrain”…
Short Description Ensuring the availability, quality and integrity of medicinal products worldwide remains critical and challenging for healthcare systems today. Patient safety is at the core of high-quality healthcare. Sub-standard drugs/poor quality products have a negative impact on the safety and effectiveness of treatments as well as directly contributing to…
Short Description The current COVID-19 pandemic highlighted the importance of efficient and robust drug regulatory authorities to ensure healthy lives and well-being for all. Well-functioning regulatory systems ensure the quality, safety and efficacy of medicines and contribute to timely access to essential medical products. Resilient regulatory systems with well-functioning structures,…